VYXEOS (Jazz Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the VYXEOS drug offered from Jazz Pharmaceuticals, Inc.. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA],Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Jazz Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: (daunorubicin and cytarabine) liposome
SUBSTANCE NAME: CYTARABINE; DAUNORUBICIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA],Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-08-03
END MARKETING DATE: 0000-00-00


VYXEOS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVYXEOS from Jazz Pharmaceuticals, Inc.
LABELER NAME: Jazz Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100; 44(mg/20mL; mg/20mL)
START MARKETING DATE: 2017-08-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68727-745_238f70d2-26f4-44c8-82fc-9aac10466f75
PRODUCT NDC: 68727-745
APPLICATION NUMBER: NDA209401

Other CYTARABINE; DAUNORUBICIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Jazz Pharmaceuticals, Inc.VYXEOS